Results 51 to 60 of about 2,328,800 (203)

Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are overlapping yet distinct conditions within the SpA spectrum. As divergent immunophenotypes may influence disease course and therapeutic response, we compared immune cell subsets, cytokine profiles, and inflammatory mediators.
Natalie Frede, Nils Craig‐Müller, Silke Kohrt, Marei‐Theresa Bott, Ulrich Salzer, Ana Cecilia Venhoff, Jens Thiel, Julia Frede, Reinhard E. Voll, Marta Rizzi, Raquel Lorenzetti, Nils Venhoff   +11 more
wiley   +1 more source

Major perirectal hematoma complicating sacroiliac joint injection

, 2013
Background: Sacroiliac joint injection is both a way of confirming sacroiliac joint pain and a therapeutic method. Findings: A 40-year-old woman was presumptively diagnosed as having sacroiliac joint dysfunction and we performed a fluoroscopically guided
Taşkaynatan, Mehmet Ali, Kesikburun, Serdar, Adıgüzel, Emre, Yaşar, Evren   +3 more
core   +1 more source

A clinical evaluation of hip joint functional ability after sacroiliac joint manipulation in patients with sacroiliac joint syndrome [PDF]

, 2005
Thesis (Masters in Technology:Chiropractic), Durban Institute of Technology, Durban, South Africa, 2005The differential diagnosis of back and leg pain should include sacroiliac joint disease as the prevalence of sacroiliac joint pain appears to range ...
Turner, Bruce
core   +1 more source

Long-term follow-up in sacroiliac joint pain patients treated with radiofrequency ablative therapy

Arquivos de Neuro-Psiquiatria, 2015
Sacroiliac joint (SIJ) pain is responsible for up to 40% of all cases of lumbar back pain. Objective Report the long-term efficacy of radiofrequency denervation for sacroiliac joint pain at six, twelve and eighteen months.Method Third-two adults ...
Flávio Ramalho Romero, Roberto Bezerra Vital, Marco Antônio Zanini, Luis Gustavo Ducati, Roberto Colichio Gabarra   +4 more
doaj   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

Arthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Laura Shaughnessy, Saori Shimizu, Paulette Williams, Rocío Lledó‐García, Gauri Utturkar, Baran Ufuktepe, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto, the Paediatric Rheumatology International Trials Organisation (PRINTO); the Pediatric Rheumatology Collaborative Study Group (PRCSG), Hermine I. Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Alberto Martini, Daniel L. Lovell, Nicolino Ruperto   +52 more
wiley   +1 more source

Impact of Dual Interleukin‐17A and Interleukin‐17F Inhibition with Bimekizumab on Inflammatory and Structural Lesions in Axial Spondyloarthritis: MRI and Radiographic Outcomes from the Phase 3 BE MOBILE 1 and 2 Studies and their Open‐Label Extension

Arthritis &Rheumatology, Accepted Article.
Objectives To evaluate the impact of bimekizumab, a dual IL‐17A and IL‐17F inhibitor, on sacroiliac joint (SIJ) and spine inflammation/structural damage in axSpA using MRIs/radiographs from the phase 3 studies BE MOBILE 1 (nr‐axSpA) and 2 (r‐axSpA) and their open‐label extension (OLE).
Walter P. Maksymowych, Sofia Ramiro, Denis Poddubnyy, Xenofon Baraliakos, Robert G.W. Lambert, Ute Massow, Tom Vaux, Chetan Prajapati, Alexander Marten, Natasha de Peyrecave, Mikkel Østergaard   +10 more
wiley   +1 more source

Validation study of a diagnostic scoring system for sacroiliac joint-related pain

Journal of Pain Research, 2018
Juichi Tonosu,1 Hiroyuki Oka,2,3 Kenichi Watanabe,1 Hiroaki Abe,1 Akiro Higashikawa,1 Koji Yamada,1 Takashi Kuniya,1 Koji Nakajima,1 Sakae Tanaka,3 Ko Matsudaira2,3 1Department of Orthopedic Surgery, Kanto Rosai Hospital, Kanagawa, Japan; 2Department of ...
Tonosu J, Oka H, Watanabe K, Abe H, Higashikawa A, Yamada K, Kuniya T, Nakajima K, Tanaka S, Matsudaira K   +9 more
doaj  

Diagnosis and interventional pain management options for sacroiliac joint pain. [PDF]

Tzu Chi Med J, 2019
The sacroiliac (SI) joint is among the most common sources of chronic low back pain, accounting for 15%–30% of patients presenting chronic low back pain.
Chuang CW, Hung SK, Pan PT, Kao MC.
europepmc   +2 more sources

Shared and Distinguishing Features of Late‐Onset Rheumatic Diseases Fulfilling Polymyalgia Rheumatica Classification Criteria

Arthritis &Rheumatology, Accepted Article.
‐
Kerem Abacar, Ala Altaie, Andrew Barr, Sarah L. Mackie, Kulveer Mankia, Dennis McGonagle   +5 more
wiley   +1 more source

Assessment of the sacroiliac joint with computed tomography motion analysis: a diagnostic study of 12 patients

Acta Orthopaedica
Background and purpose: Pain in the sacroiliac joint may be caused by abnormal joint motion. Diagnosis is mainly based on clinical tests. The aims of this study were to examine whether low-dose computed tomography with provocation of the hip could ...
Grim Olivecrona, Lena Gordon Murkes, Henrik Olivecrona, Paul Gerdhem   +3 more
doaj   +1 more source